期刊文献+

1-(4-取代苯基)-4-苯基-5-(2-羟基苄基)氨基-1,2,3-三唑类衍生物的合成及抑菌活性 被引量:4

Synthesis and Antibacterial Activities of 1-(4-Substituted phenyl)-4-phenyl-5-(2-hydroxy benzyl)amino-1,2,3-triazole Derivatives
下载PDF
导出
摘要 将邻羟苯基引入1,2,3-三唑结构中,设计合成了10个1-(4-取代苯基)-4-苯基-5-取代-1,2,3-三唑类衍生物.首先,以对位取代的芳胺为原料,经重氮化、叠氮化、闭环和缩合反应制得1-(4-取代苯基)-4-苯基-5-水杨醛亚胺-1,2,3-三唑类衍生物(3a~3e),再用硼氢化钠还原制得1-(4-取代苯基)-4-苯基-5-(2-羟基苄基)氨基-1,2,3-三唑类衍生物(4a~4e).目标化合物的结构经核磁、IR及元素分析确认.抑菌活性测试表明,当质量浓度为0.1 mg/L时,除化合物3e和4e外,所有化合物对白色念球菌的抑菌率均达95%以上,对大肠杆菌的抑菌率达85%以上,具有强抑菌活性,表明该类化合物在抗菌药物开发方面有重要应用价值. In order to search for novel and high active fungicides with triazole moiety,a series of novel 1-(4-substituted phenyl)-4-phenyl-5-substituted-1,2,3-triazole derivatives was designed and synthesized by means of combining segments o-hydroxy phenyl and 1,2,3-triazole.Firstly,1-(4-substitutedphenyl)-4-phenyl-5-(2-iminomethyl phenol)-1,2,3-triazole derivatives(3a—3e) were designed and synthesized through diazotization,azidozation,ring-closure reaction and condensation,and then were reduced by sodium borohydride to synthesize 1-(4-substituted phenyl)-4-phenyl-5-(2-hydroxy benzyl)amino-1,2,3-triazole(4a—4e).The structures of final products were determined by 1H NMR,elemental analysis and IR.The results of antibacterial activity showed that the title compounds except 3e and 4e had over 95% inhibitory rate against Monilia albican,and over 85% inhibitory rate against Escherichia coliis at a mass concentration of 0.1 mg/L.The results suggest that the title compounds might be potential candidates for antibacterial drugs.
出处 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2011年第12期2806-2811,共6页 Chemical Journal of Chinese Universities
基金 国家自然科学基金(批准号:20776114 20976135) 天津市高校科技发展基金(批准号:2006ZD33)资助
关键词 1-(4-取代苯基)-4-苯基-5-水杨醛亚胺-1 2 3-三唑 1-(4-取代苯基)-4-苯基-5-(2-羟基苄基)氨基-1 2 3-三唑 抗菌药物 抑菌活性 1-(4-Substituted phenyl)-4-phenyl-5-(2-iminomethyl phenol)-1 2 3-triazole 1-(4-Substituted phenyl)-4-phenyl-5-(2-hydroxybenzyl)amino-1 2 3-triazole Antibacterial drug Antibacterial activity
  • 相关文献

参考文献19

  • 1Ayhan K. G. , Kus C. , Coban T. , Can-Eke B. , lscan M.. J. Enzyme Inhibition and Medicinal Chemistry[J], 2004, 9(2) : 29-135.
  • 2de Wit K., Paulussen C., Matheeussen A., van Rossem K., Cos. P., Maes L.. Antimicrobial Agents Chemotherapy[J], 2010, 54(11) : 27-4929.
  • 3Thompson G. R., Wiederhold N. P.. Mycopathologic[ J], 2010, 170(5) : 291-313.
  • 4Mishra R,, Kumar R. , Kumar S. , Majeed J. , Rashid M. , Sharma S.. J. Chilean Chemical Society[J] , 2010, 55(3) : 359-362.
  • 5Gaber H. M. , Bagley M. C. , Sherif S. M. , Abdul-Raouf U. M.. J. Heterocyelic Chem. [J] , 2010, 47(5) : 1162-1170.
  • 6ZHANGYu-Xia(张玉霞) ZHOUTao(周涛) MAWan-Shan(马万山) ZHANGHai-Bin(张海滨) CHENShi-Feng(陈世峰).化学试剂,2002,:117-123.
  • 7Sharma P., Vajpayee V., Shaima J., Singh Y.. Appl. Organ. Metal. Chem. [J]. 2002, 24(11 ):774-780.
  • 8Sakiyan I., Logoglu E., Arslan S., Sari N., Sakiyan N.. Biometals[J], 2004, 17(2) : 115-120.
  • 9Scozzafava A. , Menabuoni L. , Mincione F.. Bioorg. Med. Chem. Lett. [J], 2001, 11(4) : 575-582.
  • 10Scozzafana A. , Supuran T. C.. J. Med. Chem. [J] , 2000, 43:3677-3687.

二级参考文献57

  • 1范钱君,彭伟立,沈德隆.2-嘧啶氧基-N-芳基苄胺类化合物的合成及其重排副反应[J].农药,2005,44(6):257-258. 被引量:2
  • 2冯骁,姚建华,吕龙,唐庆红,范波涛.2-嘧啶氧基-N-芳基苄胺类化合物的ALS抑制活性的QSAR研究[J].化学学报,2006,64(11):1097-1105. 被引量:10
  • 3Herbert, P. S. FEMS Microbiol. Lett. 2001, 202, 1.
  • 4McMurray, L. M.; Oethinger, M.; Levy, S. B. Nature 1998, 394, 531.
  • 5Rock, C. O.; Jackowski, S. Res. Commun. 2002, 292, 1155.
  • 6Roberts, C. W.; McLeod, R.; Rice, D. W. Mol. Biochem. Parasiteol. 2003, 126, 129.
  • 7Perozzo, R.; Kuo, M.; Sidh, A. S. Biol. Chem. 2002, 277(15), 13106.
  • 8Sharada, S. J. Med. Chem. 2004, 47, 509.
  • 9Ward, W. H.; Holdgate, G. A.; Rowsell, S.; McLean, E. G.; Pauptit, R. A.; Nichols, W. W.; Colls, J. G.; Minshull, C. A.; Jude, D. A. Biochemistry 1999, 38, 12514.
  • 10Sivaraman, S.; Zwahlen, J.; Bell, A. F.; Hedstrom, L.; Tonge, P. J. Biochemistry 2003, 42, 4406.

共引文献29

同被引文献94

  • 1Fidock D. A. , Rosenthal P. J. , Croft S. L.. Nature Reviews Drug Discovery[J] , 2004, 3:509-520.
  • 2Xiong F. , Francis J. S.. J. Nat. Prod. [J] , 1996, 59(11) : 1102-1103.
  • 3DianH., RuA. E., PeterP.. J. Nat. Prod.[J], 1997, 60(12): 1313-1316.
  • 4Schumacher R. W. , Davidson B. S.. Tetrahedron[J] , 1995, 51(37) : 10125-10130.
  • 5Marsh G. , Stenutz R. , Bergman A.. Eur. J. Org. Chem. [J] , 2003, 2003(14) : 2566-2576.
  • 6MeMurray L. M. , Oethinger, M. , Levy S. B.. Nature[J] , 1998, 394(6) : 531-532.
  • 7Heath R. J. , Yu Y. T. , Shapiro M. A.. J. Biol. Chem. [J], 1999, 273(46) : 30316-30320.
  • 8Sivaraman S. , Sullivan T. J. , Johnson F. , Novichenok P. , Cui G. , Simmerling C. , Tonge P. J.. J. Med. Chem. [J], 2004,47(3 ) : 509-518.
  • 9Rollas S. , Gulerman N. , Erdeniz H.. I1 Farmaco[J], 2002, 57(2) : 171-174.
  • 10PavanF. R., MaiaP. S., LeiteS. R. A., DeflonV. M. , BatistaA. A., SatoD. A., FranzblauS. G., LeiteC. Q. F.. Eur. J. Med. Chem. [J], 2010, 45(5) : 1898-1905.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部